Octave Q2 2026 Earnings: Distribution Growth Narrows Losses
Octave Specialty Group (NYSE: OSG) reported Q2 2026 revenue of $83.0 million, up 51% from $55.0 million, while diluted loss per share from continuing operations narrowed to $0.33 from $0.42. Insurance Distribution drove the top-line expansion, and improved results in both operating segments helped adjusted EBITDA attributable to shareholders turn positive. However, corporate costs and acquisition-related accounting expenses kept GAAP earnings in the red.
Core earnings data
Revenue growth primarily reflected the ArmadaCare acquisition and 44.1% organic growth in Insurance Distribution. Total expenses increased at a slower 21% rate, narrowing the pretax loss from continuing operations by $11.3 million.
GAAP and non-GAAP results both improved, although they showed different profitability levels. The shareholder-attributable GAAP loss remained $14.4 million, while adjusted EBITDA moved from a loss to a profit.
| Metric | Q2 2026 | Q2 2025 | YoY change |
|---|---|---|---|
| Total revenue | $83.0 million | $55.0 million | +51% |
| Total expenses | $94.7 million | $77.9 million | +21% |
| Pretax loss from continuing operations | $(11.7) million | $(23.0) million | Narrowed by $11.3 million |
| Net loss from continuing operations attributable to shareholders | $(14.4) million | $(20.5) million | Narrowed by $6.1 million |
| Diluted loss per share from continuing operations | $(0.33) | $(0.42) | Improved by $0.09 |
| Adjusted EBITDA attributable to shareholders | $3.7 million | $(4.6) million | Improved by $8.3 million |
| Adjusted net loss attributable to shareholders | $(1.8) million | $(10.6) million | Narrowed by $8.7 million |
Adjusted EBITDA and adjusted net income are non-GAAP measures and exclude items including intangible amortization, equity compensation, acquisition-related expenses, and restructuring costs.
Business and segment performance
Insurance Distribution
Insurance Distribution was the main growth engine. Revenue rose 77%, while organic growth of 44.1% showed that the improvement extended beyond acquired revenue from ArmadaCare. Premiums placed increased at a more moderate 26% rate.
| Metric | Q2 2026 | Q2 2025 | YoY change |
|---|---|---|---|
| Premiums placed | $314.4 million | $249.9 million | +26% |
| Total revenue | $58.4 million | $33.0 million | +77% |
| Organic revenue growth | 44.1% | (2.6)% | Turned positive |
| Net loss attributable to shareholders | $(3.7) million | $(7.7) million | Narrowed by $4.0 million |
| Adjusted EBITDA attributable to shareholders | $9.8 million | $2.5 million | +289% |
| Adjusted EBITDA margin attributable to shareholders | 16.8% | 7.6% | +920 basis points |
Management attributed the adjusted EBITDA increase to organic growth across the core MGA platform, ArmadaCare, and the increase in Octave’s ownership of Octave Ventures to 70% from 60%. Despite the operational improvement, the segment still recorded a GAAP loss attributable to shareholders.
Specialty P&C Insurance
Everspan’s gross premiums written declined slightly, but net premiums written and earned increased. This indicates that a larger portion of written premiums was retained on a net basis during the quarter.
| Metric | Q2 2026 | Q2 2025 | YoY change |
|---|---|---|---|
| Gross premiums written | $94.7 million | $96.2 million | (2)% |
| Net premiums written | $23.1 million | $15.2 million | +52% |
| Net premiums earned | $21.7 million | $16.2 million | +34% |
| Total revenue | $26.4 million | $21.4 million | +23% |
| Net income | $1.1 million | $0.4 million | +161% |
| Combined ratio | 100.6% | 106.7% | Improved by 610 basis points |
The combined-ratio improvement was led by a 640-basis-point reduction in the loss ratio to 61.4%. The expense ratio edged up 30 basis points to 39.2%, and the combined ratio remained slightly above the 100% underwriting breakeven level.
Distribution gains turned adjusted EBITDA positive, but GAAP earnings stayed negative
The segment contribution shows why consolidated adjusted results improved. Insurance Distribution generated $9.8 million of adjusted EBITDA attributable to shareholders, and Everspan added $1.8 million. These profits were partly offset by a $7.7 million adjusted EBITDA loss at Corporate and Other, plus $0.2 million of eliminations, leaving consolidated adjusted EBITDA attributable to shareholders at $3.7 million.
GAAP results carried additional costs not reflected in adjusted EBITDA. The reconciliation included $11.6 million of intangible amortization, $4.0 million of equity-based compensation, $1.1 million of acquisition and integration expenses, and $0.6 million of severance and restructuring expenses. Corporate and Other also recorded a $11.6 million GAAP net loss, making the holding-company cost structure an important barrier to consolidated profitability.
Balance sheet and capital position
Consolidated cash and cash equivalents, including restricted cash, declined to $79.1 million at June 30 from $93.5 million at March 31. Investments fell to $241.7 million from $254.4 million, while long-term debt increased to $155.5 million from $117.1 million.
Stockholders’ equity attributable to common shareholders decreased to $698.8 million, or $15.52 per share, from $712.6 million, or $15.83 per share, at the end of the prior quarter. Octave attributed the decline primarily to a $12 million comprehensive loss attributable to common shareholders. At the holding-company level, Octave reported $48 million of net assets, including $26 million of cash and liquid securities.
Management perspective
Management said Insurance Distribution benefited from the diversification of its MGA portfolio despite increasingly soft property-market conditions. It also described the continued repositioning of Everspan as the main context for the year-over-year improvement in the loss and combined ratios.
Octave launched an enterprise AI underwriting platform that converts unstructured submissions into decision-ready risks. Management expects the platform to accelerate underwriting decisions and help bring additional MGAs to market more quickly, although the release did not quantify its expected financial contribution.
Recent insider transactions
The supplied six-month summary reported no insider purchase activity and a zero net change in shares. Among the two-year records with an explicit transaction type and value, three direct purchases were listed; records without a transaction direction or amount are excluded below.
| Date | Insider | Transaction | Ownership type | Reported value |
|---|---|---|---|---|
| Jan. 2, 2026 | Claude L. LeBlanc | Purchase | Direct | $91,080 |
| Nov. 12, 2025 | R. Sharon Smith | Purchase | Direct | $205 |
| Oct. 1, 2025 | Claude L. LeBlanc | Purchase | Direct | $213,500 |
These disclosures describe the transactions but do not, by themselves, establish insiders’ views on Octave’s valuation or outlook.
Risks investors should monitor
- Consolidated GAAP profitability remains negative. Both operating segments improved, but corporate expenses and acquisition-related accounting costs left Octave with a $14.4 million shareholder-attributable loss from continuing operations.
- Everspan has not yet reached underwriting breakeven. Its combined ratio improved materially but remained above 100% at 100.6%.
- Liquidity declined as debt increased. Cash and investments fell sequentially while long-term debt rose by approximately $38.4 million during the quarter.
- Softer property-market conditions could affect growth and pricing. Management specifically identified increasing softness in the property market, even as portfolio diversification supported current Distribution results.
Summary
Octave’s Q2 2026 results showed substantial progress in Insurance Distribution and better underwriting performance at Everspan. Those gains turned adjusted EBITDA attributable to shareholders positive and narrowed the GAAP loss, but corporate costs, amortization, and a still-above-breakeven combined ratio prevented consolidated profitability. The next points to watch are whether Distribution can sustain its organic growth and margin improvement, whether Everspan can move its combined ratio below 100%, and how Octave manages rising debt and lower liquid assets.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles








Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.